3M Company completed sales of €500,000,000 principal amounts in each of its 3.500% Notes due 2028, 3.900% Notes due 2031 and 4.100% Notes due 2034. Investors should note that 3M intends to use the net proceeds for general corporate purposes, potentially including repayment, Redemption or refinancing of indebtedness.
Key Highlights
- The note series are issued in denominations of €100,000 and integral multiples of €1,000 above that amount.
- The offering closed on September 10, 2026, after the Underwriting agreement was signed on September 3, 2026.
- 3M intends to direct net proceeds toward general corporate purposes, including possible repayment, redemption or refinancing of indebtedness.
3M Company completed sales of €500,000,000 principal amounts in each of its 2028, 2031 and 2034 euro note series. 3M intends to use the net proceeds for general corporate purposes, which may include repaying, redeeming or refinancing indebtedness.
Euro Note Structure and Distribution
The sale closed on September 10, 2026. Each note series will exist as a permanent global security in book-entry form, registered with a common depositary or its nominee for Clearstream Banking S.A. and Euroclear Bank SA/NV. 3M CO (NYSE: MMM) are issued in denominations of €100,000 and integral multiples of €1,000 above that amount. The securities were issued under an indenture dated November 17, 2000, supplemented on July 29, 2011 and February 3, 2026. 3M’s listed note securities also include 1.500% Notes due 2026, 1.750% Notes due 2030 and 1.500% Notes due 2031.
FAQs
Q: What euro notes did 3M sell?
A: 3M sold 3.500% Notes due 2028, 3.900% Notes due 2031 and 4.100% Notes due 2034. Each series has €500,000,000 in aggregate principal amount.
Q: How will 3M use proceeds from the note sale?
A: 3M intends to use net proceeds for general corporate purposes. Those purposes may include repayment, redemption or refinancing of indebtedness.
Q: When did 3M’s euro note offering close?
A: 3M’s euro note offering closed on September 10, 2026. The underwriting agreement for the transaction was entered into on September 3, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.